/
Eur J Immunol
A design strategy to generate a SARS-CoV-2 RBD vaccine that abrogates ACE2 binding and improves neutralizing antibody responses
- C. Ratswohl
- C. Vázquez García
- A.U.W. Ahmad
- H. Gonschior
- M. Lebedin
- C.E. Silvis
- L. Spatt
- C. Gerhard
- M. Lehmann
- L.E. Sander
- F. Kurth
- S. Olsson
- K. de la Rosa